FDA Issues Health Alert for OxyElite Pro Due to Possible Linkage to Acute Hepatitis Illness

According to the U.S. Food and Drug Administration (FDA), it, along with the Centers for Disease Control and Prevention (CDC) and the Hawaii Department of Health (DOH), are investigating a growing number of reports of acute non-viral hepatitis in Hawaii.  The Hawaii DOH has reported that 24 of these cases share a common link to a dietary supplement product labeled as OxyElite Pro.  For the complete FDA alert, click here.

 

Disclaimer

This blog is provided as an informational resource only.  It is not intended to diagnose or treat any health problem or medical condition and is not a substitute for expert professional medical care.  If you suspect you may have a health problem, please consult your health care provider.

While every effort is made to ensure the accuracy of the information contained in this blog, no guarantee is made to that effect.  In addition, this blog does not endorse any drug, treatment, or therapy.